Renalytix PLC
LSE:RENX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Altria Group Inc
NYSE:MO
|
Tobacco
|
| US |
|
Medical Properties Trust Inc
NYSE:MPW
|
Real Estate
|
| US |
|
Chipotle Mexican Grill Inc
NYSE:CMG
|
Hotels, Restaurants & Leisure
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| US |
|
Arbor Realty Trust Inc
NYSE:ABR
|
Real Estate
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Monster Beverage Corp
NASDAQ:MNST
|
Beverages
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Intel Corp
NASDAQ:INTC
|
Semiconductors
|
| US |
|
Starbucks Corp
NASDAQ:SBUX
|
Hotels, Restaurants & Leisure
|
| US |
|
Ares Capital Corp
NASDAQ:ARCC
|
Financial Services
|
| US |
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
Biotechnology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.5
50.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Altria Group Inc
NYSE:MO
|
US |
|
|
Medical Properties Trust Inc
NYSE:MPW
|
US |
|
|
Chipotle Mexican Grill Inc
NYSE:CMG
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Arbor Realty Trust Inc
NYSE:ABR
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Monster Beverage Corp
NASDAQ:MNST
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Intel Corp
NASDAQ:INTC
|
US |
|
|
Starbucks Corp
NASDAQ:SBUX
|
US |
|
|
Ares Capital Corp
NASDAQ:ARCC
|
US |
|
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
US |
This alert will be permanently deleted.
Renalytix PLC
Renalytix PLC
Accumulated Depreciation
Renalytix PLC
Accumulated Depreciation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Renalytix PLC
LSE:RENX
|
Accumulated Depreciation
-$850k
|
CAGR 3-Years
-130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Accumulated Depreciation
-£2.1m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
EMIS Group PLC
LSE:EMIS
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Accumulated Depreciation
-£1.5m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Renalytix PLC
Glance View
Renalytix Plc manufactures medical devices and equipment. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2018-11-06. The firm is focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. The firm's diagnostic platform, KidneyIntelX, is designed to scale across kidney disease conditions beyond diabetic kidney disease. The firm is evaluating a range of new indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and coronavirus disease (COVID)-related kidney disease. KidneyIntelX platform facilitates the identification and promotes the effective management of patients at risk of early-stage diabetic kidney disease (DKD), progression by combining diverse data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record (HER) using a proprietary algorithm to generate a unique patient risk score.
See Also
What is Renalytix PLC's Accumulated Depreciation?
Accumulated Depreciation
-850k
USD
Based on the financial report for Jun 30, 2023, Renalytix PLC's Accumulated Depreciation amounts to -850k USD.
What is Renalytix PLC's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
-130%
Over the last year, the Accumulated Depreciation growth was -67%. The average annual Accumulated Depreciation growth rates for Renalytix PLC have been -130% over the past three years .
You don't have any saved screeners yet
